Eptinezumab demonstrated efficacy regardless of prior preventive migraine treatment failure: Post hoc DELIVER analyses

被引：0
|
作者：
Pozo-Rosich, Patricia [1 ,2 ]
Ashina, Messoud [3 ,4 ]
Tepper, Stewart J. [5 ]
Jensen, Sidsel [6 ]
Boserup, Line Pickering [6 ]
Josiassen, Mette Krog [6 ]
Sperling, Bjorn [6 ]
机构：
[1] Vall Hebron Univ Hosp & Res Inst, Headache Unit & Res Grp, Barcelona, Spain
[2] Univ Autonoma Barcelona, Barcelona, Spain
[3] Copenhagen Univ Hosp, Rigshosp, Danish Headache Ctr, Dept Neurol, Copenhagen, Denmark
[4] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[5] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[6] Lundbeck AS, Copenhagen, Denmark
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [1] Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study
    Pozo-Rosich, Patricia
    Ashina, Messoud
    Tepper, Stewart J.
    Jensen, Sidsel
    Boserup, Line Pickering
    Josiassen, Mette Krog
    Sperling, Bjorn
    NEUROLOGY AND THERAPY, 2024, 13 (02) : 339 - 353
  • [2] Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study
    Patricia Pozo-Rosich
    Messoud Ashina
    Stewart J. Tepper
    Sidsel Jensen
    Line Pickering Boserup
    Mette Krog Josiassen
    Bjørn Sperling
    Neurology and Therapy, 2024, 13 : 339 - 353
  • [3] Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial
    Ashina, Messoud
    Lipton, Richard B.
    Ailani, Jessica
    Versijpt, Jan
    Sacco, Simona
    Mitsikostas, Dimos D.
    Christoffersen, Cecilie Laurberg
    Sperling, Bjorn
    Ettrup, Anders
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (02)
  • [4] Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
    Gryglas-Dworak, Anna
    Schim, Jack
    Ettrup, Anders
    Boserup, Line Pickering
    Josiassen, Mette Krog
    Ranc, Kristina
    Sperling, Bjrn
    Ashina, Messoud
    HEADACHE, 2025, 65 (01): : 101 - 112
  • [5] Change in Migraine Diagnosis After Preventive Treatment With Eptinezumab: Post Hoc Analysis of the PROMISE Studies
    Pozo-Rosich, P.
    Dodick, D.
    Ettrup, A.
    Hirman, J.
    Cady, R.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [6] Change in migraine diagnosis after preventive treatment with eptinezumab: Post hoc analysis of the PROMISE studies
    Pozo-Rosich, P.
    Dodick, D. W.
    Ettrup, A.
    Hirman, J.
    Cady, R.
    HEADACHE, 2022, 62 : 134 - 134
  • [7] Change in Migraine Diagnosis After Preventive Treatment with Eptinezumab: Post Hoc Analysis of the PROMISE Studies
    Cady, Roger
    Pozo-Rosich, Patricia
    Dodick, David
    Ettrup, Anders
    Hirman, Joe
    Asher, Divya
    ANNALS OF NEUROLOGY, 2022, 92 : S40 - S40
  • [8] Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study
    Ashina, Messoud
    Lanteri-Minet, Michel
    Ettrup, Anders
    Christoffersen, Cecilie Laurberg
    Josiassen, Mette Krog
    Phul, Ravinder
    Sperling, Bjorn
    Pozo-Rosich, Patricia
    CEPHALALGIA, 2023, 43 (05)
  • [9] Efficacy and Safety of Eptinezumab for Migraine Prevention in Patients With 2-4 Prior Preventive Treatment Failures
    Ashina, M.
    Lanteri-Minet, M.
    Pozo-Rosich, P.
    Ettrup, A.
    Christoffersen, C. L.
    Josiassen, M. K.
    Phul, R.
    Sperling, B.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [10] Efficacy and Safety of Eptinezumab for Migraine Prevention in Patients With 2-4 Prior Preventive Treatment Failures
    Ashina, M.
    Lanteri-Minet, M.
    Pozo-Rosich, P.
    Ettrup, A.
    Christoffersen, C.
    Josiassen, M.
    Phul, R.
    Sperling, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 418 - 418
12345